Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 6 | |
Outperform | 11 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 16 analysts offering 12 month price targets for Axsome Therapeutics Inc have a median target of 117.50, with a high estimate of 180.00 and a low estimate of 71.00. The median estimate represents a 30.45% increase from the last price of 90.07.
High | 99.8% | 180.00 |
Med | 30.5% | 117.50 |
Low | -21.2% | 71.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | -7.12% |
Average growth rate | -27.55% |
More ▼
Revenue history & estimates in USD
Average growth rate | +17.61% |
Average growth rate | +146.93% |
More ▼